microdose glp 1 side effects GLP-1 Microdosing 2026: 0.1mg Chart + Tolerance Schedule Guide Microdosing GLP-1 for Weight Loss:

In April 2025, Noom sponsored a back cover advertisement in the The Wall Street Journal calling for the creation of a High-Priced Drug List by HHS

When looking at the public overall, 12% of all adults report ever taking these drugs at least in part to treat a chronic condition, including 7% of the public who say they took them primarily to treat a chronic condition and 6% who say they took these drugs to both treat a chronic condition and to lose weight

Early research shows promising results , with potential for greater weight loss than current options like Wegovy and Mounjaro but more studies are needed

Zooming in: Noom is marketing microdoses as a less expensive way to start on GLP-1 weight loss drugs with fewer side effects

As the term implies, microdosing GLP-1s entails taking a smaller dose (or a less frequent dose) than whats typically prescribed

The graphical abstract was created using BioRender